Recent News

By Category: Countermeasures

TB, HIV and malaria vaccine research gets major boost

(EurekAlert) Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.

May 7, 2013
| Filed under North America, Countermeasures, Policy & Initiatives, Public Health, and Research
Share

Scientists Pursue New Therapies as Deadly H7N9 Flu Spreads in China

(GlobalBiodefense) Researchers from the University of Maryland School of Medicine have identified an experimental drug that has shown promise in treating influenza virus, and preventing lung injury and death from the virus.

May 6, 2013
| Filed under North America and Countermeasures
Share

Days After Ricin Mailings, Pentagon Says it Wants a Vaccine

(GlobalSecurityNewswire) The United States needs a vaccine to protect troops against ricin, the Defense Department said in an announcement issued days after envelopes filled with the deadly toxin were mailed to President Obama and two Mississippi public officials. No antidote or means of prevention yet exists for ricin, which can be lethal in minute quantities Read More »

May 1, 2013
| Filed under North America and Countermeasures
Share

In Animal Model Of Hepatitis B Infection, New Drug Stimulates Immune System To Kill Infected Cells

(MedicalNewsToday) A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.

April 30, 2013
| Filed under North America and Countermeasures
Share

Hepatitis C drug nears approval

(Nature) A highly anticipated new drug for treating hepatitis C has sailed through its first phase III clinical trials, according to two papers published today in the New England Journal of Medicine.